Thyroid Cancer- To Treat or Not To Treat

Share Button


You Owe it to Yourself to learn the Risks and Benefits of Your Recommended Treatment for Both Conventional and Non-Conventional Therapies-

Have you been diagnosed with thyroid cancer? If your doctor says that you should undergo therapy that’s covered by your health insurance, you do what he/she says, right?

The fact is, only you can make the right decision for you. Any cancer therapy can result in side effects. Some negative, some not so negative.

When I was diagnosed with cancer, I did everything my oncologist told me to do. Boy was that a mistake. This website is populated with the phrase “I wish I knew then what I know now.”

Image result for photo of thyroid cancer

Please don’t misunderstand me. I’m not saying that conventional oncology is evil. I’m simply saying that conventional oncology is in the business of treating cancer. And that you may choose not to undergo conventional treatment.

Further, newly diagnosed cancer patients don’t know what they don’t know.  By learning the risk and benefits of any therapy, conventional or non-conventional, you can make the best decision for you.

I am both a long-term cancer survivor and cancer coach. My role is to educate cancer patients and survivors.

To learn more about non-toxic, non-conventional cancer therapies scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Is Thyroid Cancer Being Overtreated?

“From 1975 to 2009, the incidence rate tripled from 4.9 to 14.3 per 100,000 people, driven by a jump in papillary thyroid cancer during that time (from 3.4 to 12.5 per 100,000), according to Gilbert Welch, MD, MPH, and Louise Davies, MD, of Dartmouth…

Radioiodine for Most Papillary Thyroid Cancers Is Overtreatment, Says Expert

“A prominent expert in the field argues that for the majority of patients who receive it, radioiodine remnant ablation therapy (RRA) represents overtreatment, with no documented benefit and a possibility for harm. 

  • The majority of patients (>80%) with thyroid cancer have papillary thy. cancer (PTC),
  • The majority of PTC patients (about 80% to 85%) are considered low risk
  • These patients, after surgery, have a less than 1% chance of dying from their disease

Thyroid Cancer: Quarter of Patients Receive RAI Unnecessarily

“Some have even suggested that RAI is overtreatment, with no evidence of benefit in low-risk cancer.  Current guidelines do not recommend adjuvant RAI for patients with medullary thyroid cancer, anaplastic thyroid cancer…

  • RAI therapy can be expensive
  • Is associated with many complications, including radiation-induced malignancies.
  • Because thyroid cancer affects young adults, these effects can persist throughout life

Radioactive iodine (RAI) was inappropriately used in 1.6% of the 3095 patients with anaplastic thyroid cancer, 3.4% of the 6375 patients with medullary thyroid cancer, and 23.3% of the 60,586 patients with PTMC.

Average cost per patient ranged from $5429 to $9105.

Patterns of Use and Cost for Inappropriate Radioactive Iodine Treatment for Thyroid Cancer in the United States

Based on current guidelines, adjuvant radioactive iodine (RAI) therapy is not recommended for localized papillary thyroid tumors measuring 1 cm or less, medullary thyroid cancer (MTC), and anaplastic thyroid cancer (ATC).1– 3 Nevertheless, previous studies have reported the use of RAI in the treatment of these cancers.…”

Leave a Comment:

Add Your Reply